ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,102,000 | -89.5% | 6,405 | -92.3% | 0.00% | -90.9% |
Q2 2021 | $10,467,000 | -50.8% | 83,412 | -46.8% | 0.01% | -57.7% |
Q1 2021 | $21,258,000 | -6.3% | 156,761 | -11.6% | 0.03% | -13.3% |
Q4 2020 | $22,684,000 | +5.0% | 177,304 | -7.7% | 0.03% | -14.3% |
Q3 2020 | $21,611,000 | +452.4% | 192,043 | +367.7% | 0.04% | +400.0% |
Q2 2020 | $3,912,000 | -0.5% | 41,061 | -6.1% | 0.01% | -22.2% |
Q1 2020 | $3,931,000 | +816.3% | 43,736 | +440.9% | 0.01% | +800.0% |
Q4 2019 | $429,000 | -43.3% | 8,086 | -50.2% | 0.00% | -50.0% |
Q1 2019 | $756,000 | -48.5% | 16,238 | -51.8% | 0.00% | -33.3% |
Q4 2018 | $1,467,000 | -43.2% | 33,683 | -25.4% | 0.00% | -40.0% |
Q3 2018 | $2,583,000 | +104.2% | 45,128 | +39.5% | 0.01% | +66.7% |
Q1 2018 | $1,265,000 | +96.4% | 32,354 | +113.2% | 0.00% | +50.0% |
Q4 2017 | $644,000 | -47.7% | 15,178 | -68.5% | 0.00% | -50.0% |
Q4 2016 | $1,231,000 | +7.9% | 48,251 | +53.0% | 0.00% | +33.3% |
Q3 2016 | $1,141,000 | – | 31,533 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |